Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Electroconvulsive Therapy During Anticoagulant Therapy.

Henri Loo1, Henry Cuche, Chawki Benkelfat

  • 1Teaching Hospital, Department of Mental Health and Therapeutics, Sainte-Anne Hospital, Paris, France.

Convulsive Therapy
|January 1, 1985
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Testing PET-[ <sup>11</sup> C]ABP688 as a tool to quantify glutamate release <i>in vivo</i>.

Imaging neuroscience (Cambridge, Mass.)·2025
Same author

Quantification of [<sup>11</sup>C]ABP688 Binding to mGluR5 in Human Brain using Cerebellum as Reference Region: Biological Interpretation and Limitations.

Current neuropharmacology·2025
Same author

Radiosynthesis and <i>In Vivo</i> Evaluation of Four Positron Emission Tomography Tracer Candidates for Imaging of Melatonin Receptors.

ACS chemical neuroscience·2022
Same author

Externalizing Risk Pathways for Adolescent Substance Use and Its Developmental Onset: A Canadian Birth Cohort Study: Trajectoires de comportements extériorisés et le risque pour l'initiation et l'usage de substances des adolescents : Une étude de cohorte de naissance canadienne.

Canadian journal of psychiatry. Revue canadienne de psychiatrie·2021
Same author

Metabotropic glutamate type 5 receptor binding availability during dextroamphetamine sensitization in mice and humans.

Journal of psychiatry & neuroscience : JPN·2020
Same author

mGlu5 receptor availability in youth at risk for addictions: effects of vulnerability traits and cannabis use.

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology·2020

Electroconvulsive therapy (ECT) can be safely administered to depressed patients undergoing anticoagulant therapy. This review indicates ECT is a viable treatment option when other therapies fail or are contraindicated.

Area of Science:

  • Neuroscience
  • Psychiatry
  • Pharmacology

Background:

  • Anticoagulant therapy is crucial for preventing thromboembolic events.
  • Electroconvulsive therapy (ECT) is an effective treatment for severe depression.
  • Concerns exist regarding the safety of ECT in patients on anticoagulants due to bleeding risks.

Purpose of the Study:

  • To evaluate the safety and feasibility of administering ECT to patients receiving anticoagulant medications.
  • To determine if ECT can be successfully performed without significant complications in this patient population.

Main Methods:

  • Review of cases where ECT was administered to patients on anticoagulant therapy (heparin and acenocoumarol).
  • Close monitoring of blood coagulation values.
  • Adjustment of succinylcholine dosage to ensure adequate muscle paralysis during ECT seizures.

Related Experiment Videos

Main Results:

  • Successful completion of five courses of ECT in depressed patients maintained on anticoagulants.
  • No major bleeding complications reported during or after ECT.
  • ECT was utilized in patients unresponsive to drug therapy or with cardiovascular conditions precluding antidepressant drugs.

Conclusions:

  • Electroconvulsive therapy (ECT) can be safely administered to patients undergoing anticoagulant therapy.
  • ECT is a viable and safe treatment option for severe depression in patients requiring anticoagulation.
  • Careful monitoring and appropriate adjustments in anesthetic agents are key to ensuring safety.